BEYOND THE SCALE: COMPREHENSIVE TREATMENT OPTIONS FOR YOUTH OBESITY

Keywords: Childhood Obesity, Obesity Treatment, Physical Activity, Liraglutide, Semaglutide, Bariatric Surgery

Abstract

Introduction: This review aims to examine the multifactorial nature of childhood obesity by exploring its prevalence, diagnostic standards, and associated metabolic and psychological complications, as well as evaluating current strategies for management.

Materials and Methods: A comprehensive review of the literature was conducted using the PubMed and Google Scholar databases using the following keywords: “childhood obesity”, “obesity treatment”, “Mediterranean diet”, “DASH diet”. physical activity”, “liraglutide”, “semaglutide”, “phentermine-topiramate”, “setmelanotide” and “bariatric surgery”.

Summary: Childhood obesity is a growing global issue with serious health consequences that often persist into adulthood. It stems from multiple factors like diet, activity levels, and environment. Healthy diets (e.g., Mediterranean, DASH) and at least 60 minutes of daily physical activity are key for prevention and treatment. Medications like GLP-1 receptor agonists (e.g., liraglutide, semaglutide) may help in severe cases, while bariatric surgery is an option for extreme, treatment-resistant obesity. Effective management requires a combination of lifestyle changes and medications.      

Conclusions: Combating childhood obesity requires a personalized approach combining lifestyle changes, nutrition education, physical activity, and, when needed, medication or surgery. Early intervention is vital to reduce long-term health risks and psychological effects. Treatment should involve multidisciplinary teams, including pediatricians, dietitians, psychologists, and specialists. Future efforts must improve public health policies, promote healthy environments, and conduct long-term studies on treatments. Continued innovation in diagnosis and prevention is essential to tackle this growing epidemic and improve children's quality of life.

References

Smith JD, Fu E, Kobayashi MA. Prevention and Management of Childhood Obesity and Its Psychological and Health Comorbidities. Annu Rev Clin Psychol. 2020 May 7;16:351-378. doi: 10.1146/annurev-clinpsy-100219-060201. Epub 2020 Feb 25. PMID: 32097572; PMCID: PMC7259820.

Pereira AR, Oliveira A. Dietary Interventions to Prevent Childhood Obesity: A Literature Review. Nutrients. 2021 Sep 28;13(10):3447. doi: 10.3390/nu13103447. PMID: 34684448; PMCID: PMC8537925.

Morales Camacho WJ, Molina Díaz JM, Plata Ortiz S, Plata Ortiz JE, Morales Camacho MA, Calderón BP. Childhood obesity: Aetiology, comorbidities, and treatment. Diabetes Metab Res Rev. 2019 Nov;35(8):e3203. doi: 10.1002/dmrr.3203. Epub 2019 Jul 25. PMID: 31299135.

Kumar S, Kelly AS. Review of Childhood Obesity: From Epidemiology, Etiology, and Comorbidities to Clinical Assessment and Treatment. Mayo Clin Proc. 2017 Feb;92(2):251-265. doi: 10.1016/j.mayocp.2016.09.017. Epub 2017 Jan 5. PMID: 28065514.

Chen T, Lin J, Lin Y, Xu L, Lu D, Li F, Hou L, Yu CCW. Effects of aerobic exercise and resistance exercise on physical indexes and cardiovascular risk factors in obese and overweight school-age children: A systematic review and meta-analysis. PLoS One. 2021 Sep 20;16(9):e0257150. doi: 10.1371/journal.pone.0257150. PMID: 34543302; PMCID: PMC8452003.

Umekar S, Joshi A. Obesity and Preventive Intervention Among Children: A Narrative Review. Cureus. 2024 Feb 20;16(2):e54520. doi: 10.7759/cureus.54520. PMID: 38516445; PMCID: PMC10955407.

Polak-Szczybyło E. Low-Grade Inflammation and Role of Anti-Inflammatory Diet in Childhood Obesity. Int J Environ Res Public Health. 2023 Jan 17;20(3):1682. doi: 10.3390/ijerph20031682. PMID: 36767041; PMCID: PMC9914259.

Calcaterra V, Verduci E, Milanta C, Agostinelli M, Bona F, Croce S, Valsecchi C, Avanzini MA, Zuccotti G. The Benefits of the Mediterranean Diet on Inflamm-Aging in Childhood Obesity. Nutrients. 2024 Apr 25;16(9):1286. doi: 10.3390/nu16091286. PMID: 38732533; PMCID: PMC11085692.

Paula Bricarello L, Poltronieri F, Fernandes R, Retondario A, de Moraes Trindade EBS, de Vasconcelos FAG. Effects of the Dietary Approach to Stop Hypertension (DASH) diet on blood pressure, overweight and obesity in adolescents: A systematic review. Clin Nutr ESPEN. 2018 Dec;28:1-11. doi: 10.1016/j.clnesp.2018.09.003. Epub 2018 Oct 5. PMID: 30390863.

Dhuli K, Naureen Z, Medori MC, Fioretti F, Caruso P, Perrone MA, Nodari S, Manganotti P, Xhufi S, Bushati M, Bozo D, Connelly ST, Herbst KL, Bertelli M. Physical activity for health. J Prev Med Hyg. 2022 Oct 17;63(2 Suppl 3):E150-E159. doi: 10.15167/2421-4248/jpmh2022.63.2S3.2756. PMID: 36479484; PMCID: PMC9710390.

Lee S, Deldin AR, White D, Kim Y, Libman I, Rivera-Vega M, Kuk JL, Sandoval S, Boesch C, Arslanian S. Aerobic exercise but not resistance exercise reduces intrahepatic lipid content and visceral fat and improves insulin sensitivity in obese adolescent girls: a randomized controlled trial. Am J Physiol Endocrinol Metab. 2013 Nov 15;305(10):E1222-9. doi: 10.1152/ajpendo.00285.2013. Epub 2013 Sep 17. PMID: 24045865; PMCID: PMC3840217.

Sirico F, Bianco A, D'Alicandro G, Castaldo C, Montagnani S, Spera R, Di Meglio F, Nurzynska D. Effects of Physical Exercise on Adiponectin, Leptin, and Inflammatory Markers in Childhood Obesity: Systematic Review and Meta-Analysis. Child Obes. 2018 May/Jun;14(4):207-217. doi: 10.1089/chi.2017.0269. Epub 2018 May 15. PMID: 29762052; PMCID: PMC5994661.

Wyszyńska J, Ring-Dimitriou S, Thivel D, Weghuber D, Hadjipanayis A, Grossman Z, Ross-Russell R, Dereń K, Mazur A. Physical Activity in the Prevention of Childhood Obesity: The Position of the European Childhood Obesity Group and the European Academy of Pediatrics. Front Pediatr. 2020 Nov 5;8:535705. doi: 10.3389/fped.2020.535705. PMID: 33224905; PMCID: PMC7674497.

Nowicka P, Flodmark CE. Physical activity-key issues in treatment of childhood obesity. Acta Paediatr. 2007 Apr;96(454):39-45. doi: 10.1111/j.1651-2227.2007.00169.x. PMID: 17313414.

Priftis N, Panagiotakos D. Screen Time and Its Health Consequences in Children and Adolescents. Children (Basel). 2023 Oct 8;10(10):1665. doi: 10.3390/children10101665. PMID: 37892328; PMCID: PMC10605067.

Ladenheim EE. Liraglutide and obesity: a review of the data so far. Drug Des Devel Ther. 2015 Mar 30;9:1867-75. doi: 10.2147/DDDT.S58459. PMID: 25848222; PMCID: PMC4386791.

Jebeile H, Kelly AS, O'Malley G, Baur LA. Obesity in children and adolescents: epidemiology, causes, assessment, and management. Lancet Diabetes Endocrinol. 2022 May;10(5):351-365. doi: 10.1016/S2213-8587(22)00047-X. Epub 2022 Mar 3. PMID: 35248172; PMCID: PMC9831747.

Nicolucci A, Maffeis C. The adolescent with obesity: what perspectives for treatment? Ital J Pediatr. 2022 Jan 15;48(1):9. doi: 10.1186/s13052-022-01205-w. PMID: 35033162; PMCID: PMC8761267.

Kelly AS, Auerbach P, Barrientos-Perez M, Gies I, Hale PM, Marcus C, Mastrandrea LD, Prabhu N, Arslanian S; NN8022-4180 Trial Investigators. A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity. N Engl J Med. 2020 May 28;382(22):2117-2128. doi: 10.1056/NEJMoa1916038. Epub 2020 Mar 31. PMID: 32233338.

Fox CK, Barrientos-Pérez M, Bomberg EM, Dcruz J, Gies I, Harder-Lauridsen NM, Jalaludin MY, Sahu K, Weimers P, Zueger T, Arslanian S; SCALE Kids Trial Group. Liraglutide for Children 6 to <12 Years of Age with Obesity - A Randomized Trial. N Engl J Med. 2025 Feb 6;392(6):555-565. doi: 10.1056/NEJMoa2407379. Epub 2024 Sep 10. PMID: 39258838.

O'Hara V, Cuda S, Kharofa R, Censani M, Conroy R, Browne NT. Clinical review: Guide to pharmacological management in pediatric obesity medicine. Obes Pillars. 2023 Apr 27;6:100066. doi: 10.1016/j.obpill.2023.100066. PMID: 37990657; PMCID: PMC10661861.

Weghuber D, Barrett T, Barrientos-Pérez M, Gies I, Hesse D, Jeppesen OK, Kelly AS, Mastrandrea LD, Sørrig R, Arslanian S; STEP TEENS Investigators. Once-Weekly Semaglutide in Adolescents with Obesity. N Engl J Med. 2022 Dec 15;387(24):2245-2257. doi: 10.1056/NEJMoa2208601. Epub 2022 Nov 2. PMID: 36322838; PMCID: PMC9997064.

Maffeis C, Olivieri F, Valerio G, Verduci E, Licenziati MR, Calcaterra V, Pelizzo G, Salerno M, Staiano A, Bernasconi S, Buganza R, Crinò A, Corciulo N, Corica D, Destro F, Di Bonito P, Di Pietro M, Di Sessa A, deSanctis L, Faienza MF, Filannino G, Fintini D, Fornari E, Franceschi R, Franco F, Franzese A, Giusti LF, Grugni G, Iafusco D, Iughetti L, Lera R, Limauro R, Maguolo A, Mancioppi V, Manco M, Del Giudice EM, Morandi A, Moro B, Mozzillo E, Rabbone I, Peverelli P, Predieri B, Purromuto S, Stagi S, Street ME, Tanas R, Tornese G, Umano GR, Wasniewska M. The treatment of obesity in children and adolescents: consensus position statement of the Italian society of pediatric endocrinology and diabetology, Italian Society of Pediatrics and Italian Society of Pediatric Surgery. Ital J Pediatr. 2023 Jun 8;49(1):69. doi: 10.1186/s13052-023-01458-z. PMID: 37291604; PMCID: PMC10249209.

Guerciolini R. Mode of action of orlistat. Int J Obes Relat Metab Disord. 1997 Jun;21 Suppl 3:S12-23. PMID: 9225172.

Nikniaz Z, Nikniaz L, Farhangi MA, Mehralizadeh H, Salekzamani S. Effect of Orlistat on anthropometrics and metabolic indices in children and adolescents: a systematic review and meta-analysis. BMC Endocr Disord. 2023 Jul 7;23(1):142. doi: 10.1186/s12902-023-01390-7. PMID: 37420181; PMCID: PMC10327388.

Bansal AB, Patel P, Al Khalili Y. Orlistat. [Updated 2024 Feb 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK542202/

Johnson DB, Quick J. Topiramate and Phentermine. [Updated 2023 Mar 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482165/

Woodard K, Louque L, Hsia DS. Medications for the treatment of obesity in adolescents. Ther Adv Endocrinol Metab. 2020 May 27;11:2042018820918789. doi: 10.1177/2042018820918789. PMID: 32523671; PMCID: PMC7257846.

Ali Ibrahim AI, Mendoza B, Stanford FC, Malhotra S. Real-World Experience of the Efficacy and Safety of Phentermine Use in Adolescents: A Case Series. Child Obes. 2023 Dec;19(8):535-540. doi: 10.1089/chi.2022.0147. Epub 2022 Dec 19. PMID: 36576420; PMCID: PMC10698794.

Ryder JR, Kaizer A, Rudser KD, Gross A, Kelly AS, Fox CK. Effect of phentermine on weight reduction in a pediatric weight management clinic. Int J Obes (Lond). 2017 Jan;41(1):90-93. doi: 10.1038/ijo.2016.185. Epub 2016 Oct 24. PMID: 27773937; PMCID: PMC5891125.

Wajid I, Vega A, Thornhill K, Jenkins J, Merriman C, Chandler D, Shekoohi S, Cornett EM, Kaye AD. Topiramate (Topamax): Evolving Role in Weight Reduction Management: A Narrative Review. Life (Basel). 2023 Aug 31;13(9):1845. doi: 10.3390/life13091845. PMID: 37763249; PMCID: PMC10532729.

Styne DM, Arslanian SA, Connor EL, Farooqi IS, Murad MH, Silverstein JH, Yanovski JA. Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2017 Mar 1;102(3):709-757. doi: 10.1210/jc.2016-2573. PMID: 28359099; PMCID: PMC6283429.

Janson A, Järvholm K, Sjögren L, Dahlgren J, Beamish AJ, Gronowitz E, Olbers T. Metabolic and Bariatric Surgery in Adolescents: For Whom, When, and How? Horm Res Paediatr. 2023;96(6):609-619. doi: 10.1159/000524002. Epub 2022 Mar 9. PMID: 35263750.

Thenappan A, Nadler E. Bariatric Surgery in Children: Indications, Types, and Outcomes. Curr Gastroenterol Rep. 2019 Apr 25;21(6):24. doi: 10.1007/s11894-019-0691-8. PMID: 31025124.

Järvholm K, Olbers T, Marcus C, Mårild S, Gronowitz E, Friberg P, Johnsson P, Flodmark CE. Short-term psychological outcomes in severely obese adolescents after bariatric surgery. Obesity (Silver Spring). 2012 Feb;20(2):318-23. doi: 10.1038/oby.2011.310. Epub 2011 Oct 13. PMID: 21996668.

Inge TH, Jenkins TM, Xanthakos SA, Dixon JB, Daniels SR, Zeller MH, Helmrath MA. Long-term outcomes of bariatric surgery in adolescents with severe obesity (FABS-5+): a prospective follow-up analysis. Lancet Diabetes Endocrinol. 2017 Mar;5(3):165-173. doi: 10.1016/S2213-8587(16)30315-1. Epub 2017 Jan 6. PMID: 28065736; PMCID: PMC8282411.

Views:

0

Downloads:

0

Published
2025-12-30
Citations
How to Cite
Magdalena Jabłonowska, & Paulina Grzeszczuk. (2025). BEYOND THE SCALE: COMPREHENSIVE TREATMENT OPTIONS FOR YOUTH OBESITY. International Journal of Innovative Technologies in Social Science, 5(4(48). https://doi.org/10.31435/ijitss.4(48).2025.4236